Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.62 |
| ▸ | CTSD | P07339 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | CTNNB1 | P35222 | 3/20 | 0.55 |
| ▸ | WNT3A | P56704 | 3/20 | 0.55 |
| ▸ | IDO1 | P14902 | 1/20 | 0.54 |
| ▸ | TDO2 | P48775 | 1/20 | 0.54 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | STAT3 | P40763 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21128714 | 0.84 | NPC1 (0.83) | NPC1CTSDL3MBTL1ALDH1A1KMT2A | |
| SCHEMBL29987209 | 0.84 | NPC1 (0.83) | NPC1CTSDL3MBTL1ALDH1A1KMT2A | |
| SCHEMBL15979734 | 0.84 | CTNNB1 (0.71) | NPC1CTSDL3MBTL1ALDH1A1KMT2A | |
| SCHEMBL8544356 | 0.84 | HPGD (0.56) | NPC1L3MBTL1ALDH1A1KMT2ALMNA | |
| SCHEMBL29738645 | 0.82 | NPC1 (0.64) | NPC1CTSDL3MBTL1ALDH1A1KMT2A | |
| SCHEMBL878658 | 0.82 | NPC1 (0.64) | NPC1CTSDL3MBTL1ALDH1A1KMT2A | |
| SCHEMBL3702934 | 0.82 | NPC1 (0.64) | NPC1CTSDL3MBTL1ALDH1A1KMT2A | |
| SCHEMBL1448202 | 0.82 | NPC1 (0.64) | NPC1CTSDL3MBTL1ALDH1A1KMT2A | |
| SCHEMBL7460882 | 0.82 | HDAC8 (0.64) | NPC1CTSDL3MBTL1ALDH1A1KMT2A | |
| SCHEMBL8569591 | 0.81 | HDAC8 (0.67) | NPC1CTSDL3MBTL1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107629069-B | Preparation method of acetyl coenzyme A carboxylase inhibitor | 中国药科大学 | 2023-01-24 | — | — | CN | claimed |
| CN-107629069-A | The preparation method of a kind of acetyl-CoA carboxylase inhibitor | 中国药科大学 | 2018-01-26 | — | — | CN | claimed |
| CN-118027395-B | Coating material, preparation method and application thereof, and lithium battery diaphragm | 安徽壹石通材料科学研究院有限公司 | 2025-04-29 | — | — | CN | disclosed |
| CN-118027395-A | Coating material, preparation method and application thereof, and lithium battery diaphragm | 安徽壹石通材料科学研究院有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-107629069-B | Preparation method of acetyl coenzyme A carboxylase inhibitor | 中国药科大学 | 2023-01-24 | — | — | CN | disclosed |
| CN-107629069-A | The preparation method of a kind of acetyl-CoA carboxylase inhibitor | 中国药科大学 | 2018-01-26 | — | — | CN | disclosed |
| WO-2013055944-A2 | LABILE ESTERS OF AGROCHEMICALS FOR CONTROLLED RELEASE AND REDUCTION OF OFF-SITE MOVEMENT | MONSANTO TECHNOLOGY LLC (US) | 2013-04-18 | — | — | WO | disclosed |
| US-6888012-B2 | Reducing an alpha -haloketone compound by asymmetric hydrogen transfer in presence of a group 9 transition metal compound having a substituted or unsubstituted cyclopentadienyl group and an optically active diamine compound | AJINOMOTO CO., INC. (JP) | 2005-05-03 | — | — | US | disclosed |
| US-20040082820-A1 | Hydrogen transfer reduction; useful as intermediate for production of pharmaceuticals/agricultural chemicals | AJINOMOTO CO., INC. (JP) | 2004-04-29 | — | — | US | disclosed |
| EP-1346972-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE HALOHYDRIN COMPOUND | Ajinomoto Co., Inc. (JP) | 2003-09-24 | — | — | EP | disclosed |
| EP-0493617-B1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE (-)-2-HALO-1-(SUBSTITUTED PHENYL)ETHANOL | KANEGAFUCHI CHEMICAL IND (JP) | 1999-10-06 | — | — | EP | disclosed |
| CN-1089608-A | Imidazopyridine | MERCK PATENT GMBH (DE) | 1994-07-20 | — | — | CN | disclosed |
| US-4131686-A | ANTIDIABETIC | TANABE SEIYAKU CO., LTD. (JP) | 1978-12-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040082820-A1 | Hydrogen transfer reduction; useful as intermediate for production of pharmaceuticals/agricultural chemicals | DHPS, HDHD5, HYPK | NPC1 2153/4885CTSD 2028/4885L3MBTL1 4143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.